Increase in Ceramide Level after Application of Various Sizes of Sphingomyelin Liposomes to a Cultured Human Skin Model
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Introduction
The stratum corneum is the primary barrier against the permeation of therapeutic drugs and cosmetic ingredients through the skin [1, 2] . The stratum corneum has a special structure, with keratinocytes acting as bricks and intercellular lipids acting as mortar [3, 4] . The intercellular lipids of the stratum corneum include ceramides, cholesterol, cholesterol esters, and fatty acids [5, 6] . Disruption of or a lack of stratum corneum lipids decreases the effectiveness of the barrier function of the skin and skin moisturization, causing dry skin and sometimes skin disease. In particular, ceramides, the primary constituents of intercellular lipids, play the most important roles in the barrier function of the stratum corneum [7, 8] . It was also reported that the sphingolipid concentration was significantly decreased and the barrier function of the skin was inhibited in atopic dermatitis patients [8] [9] [10] .
Ceramides make up 30-40% of the stratum corneum by weight [11, 12] . The 9 major stratum corneum ceramide species are generated through 2 biosynthesis pathways: glucosylceramide hydrolysis through glucocerebrosidase and sphingomyelin (SPM) hydrolysis through sphingomyelinase. Generally, ceramide II and V are generated from SPM, and ceramide III, IV, and VI are generated from glucosylceramide [9, 13, 14] . SPM is a sphingolipid that is found in the cell membranes of mammalian cells. SPM contains phosphorylcholine and ceramide. It is hydrolyzed by sphingomyelinase in the granular layer of the skin to generate ceramide and phosphocholine [15] . SPM is difficult to formulate in topical formulations and cosmetics since it is not soluble or stable in aqueous formulations, which are frequently used for cosmetics.
Recently, reconstructed cultured human skin models (cultured skin models) have been researched and developed as a promising alternative membrane for human and animal skins. Three-dimensional human skin models, such as EPISKIN , have been used as materials in various studies [16] . In this study, the LabCyte Epi-Model (which consists of human keratinocytes) was used as a three-dimensional model.
We have previously reported that the application of SPM-based liposomes (SPM-L) to a three-dimensional cultured human skin model increased its type II ceramide content [17] . In the present study, we prepared various sizes of SPM-L and applied them to the aforementioned three-dimensional cultured human skin model in order to evaluate which size of SPM-L is most effective at increasing its ceramide level.
Materials and Methods
Materials SPM (from milk) was purchased from NOF Corporation (Tokyo, Japan). Hydroxy and non-hydroxy ceramide standards were obtained from Matreya, LLC (Pleasant Gap, Pa., USA). Type III and VI ceramide were obtained from Evonik Goldschmidt GmbH (Essen, Germany). LabCyte Epi-Model (a three-dimensional cultured human skin model) medium and enhanced keratinization medium were purchased from Japan Tissue Engineering Co., Ltd. (Gamagori, Japan). PBS powder was obtained from Sigma (St. Louis, Mo., USA). All other reagents were obtained commercially and used without further purification. Silica gel 60 (Merck, Darmstadt, Germany) was used for the HPTLC plate.
Preparation of SPM-L SPM-L were prepared using a thin layer film and the freezethawing method [18] . SPM (77.95 mg) was dissolved in 1 ml chloroform (100 m M ). The chloroform was then evaporated and dried using a rotary evaporator under 40 ° C and 50 hPa, before being stored in vacuo for at least 1 h. The resulting thin lipid film was hydrated with PBS (pH 7.4). Then, the liposomes were subjected to freezing and thawing for 5 cycles with liquid nitrogen and extruded 5 times through polycarbonate double-membrane filters using an extruder (pore size: 100, 200, or 400 nm; Nucleopore, Costar, Cambridge, Mass., USA). Finally, the SPM-L suspension was separated by ultracentrifugation at 250,000 g for 15 min (Himac CS100 GXL, Hitachi, Tokyo, Japan). The resultant liposomal pellets were resuspended in PBS (pH 7.4) or culture medium.
Stability of the Diameter of the SPM-L
The diameters of the SPM-L were measured by dynamic light scattering using a Zetasizer (3000HSA, Malvern, London, UK). The diameters of the liposomes in the PBS were measured at 0, 1, 2, 4, and 7 days, and those of the liposomes in the culture medium were measured at 0, 6, 24, and 48 h.
Application of SPM-L to the Basal Layer Side of the LabCyte Epi-Model and the Extraction of Various Types of Ceramide
One percent of SPM-L of various sizes in physiological saline or saline alone (control) (1.0 ml each) was applied to the basal layer side of the LabCyte Epi-Model for 6 h. The cell cultures were grown in 5% CO 2 at 37 ° C; 1.0 ml of the culture medium containing ascorbic acid (final concentration: 25 g/ml) was then exchanged for enhanced keratinization medium. After 24 h, the ceramide molecules were extracted from the cultured skin model using 6.0 ml chloroform:methanol (2: 1 v/v).
Application of SPM-L to the Stratum Corneum Side of the LabCyte Epi-Model and Extraction of Ceramide
One percent of SPM-L of various sizes in the culture medium or medium alone (control) (0.3 ml each) was applied to the stratum corneum side of the LabCyte Epi-Model for 7 days. Cultures of the LabCyte Epi-Model were grown (5% CO 2 and 37 ° C). Medium (1.0 ml) was changed every day. After 7 days, 1.0 ml of the culture medium containing ascorbic acid was then exchanged for enhanced keratinization medium in 24 h.
Extraction Method and Ceramide Analysis
Various ceramides in the LabCyte Epi-Model were extracted using the method of Bligh and Dyer [19] . Briefly, LabCyte EpiModel was dissolved in 6 ml chloroform:methanol (2:1 v/v) and sonicated (70 W, 10 min) by a probe-type sonicator (Sonifire B-12, Branson Ultrasonics, Conn., USA). The ceramide extracted solution was dried by the nitrogen gas, and resolved 0.4 ml of chloro form:methanol (2:1 v/v). Various ceramide extracts were prepared.
Ceramide Analysis by HPTLC
Various ceramide extracts were separated using an HPTLC plate (Silica Gel 60, Merck). The HPTLC was developed twice with chloroform:methanol:acetic acid (190: 9:1 v/v). The ceramide molecules were visualized by treatment with 10% CuSO 4 , 8% H 3 PO 4 aqueous solution, and heated to 180 ° C for 10 min. The amounts of the various types of ceramide on the HPTLC plate were quantitatively determined using a densitometer.
Data Analysis
All experiments were performed 3-5 times, and the data are shown as means 8 SD. Dunnett's multiple comparison test was performed for statistical analyses. 
Results

Change in the Diameter of the SPM-L
The diameters of the SPM-L were analyzed by dynamic laser light scattering. Figure 1 shows the changes in particle diameters of the SPM-L in PBS and culture medium, respectively. The mixtures (SPM-L with PBS or culture medium) were incubated for different periods of time (SPM-L in PBS: time = 0, 1, 2, 4, or 7 days; SPM-L in culture medium: time = 0, 6, 24, or 48 h) before their diameter change was measured. The diameter of the small SPM-L (110 and 190 nm) did not change in PBS or culture medium. In contrast, the diameter of the large SPM-L (240 nm and without sizing) was greatly increased in a time-dependent manner.
Change in Ceramide Contents after Application of SPM-L to the Basal Layer Side of the Cultured Skin Model
One percent of different-sized SPM-L was applied to the basal layer side of the LabCyte Epi-Model for 6 h. The skin model was then cultured in enhanced keratinization medium containing ascorbic acid for 24 h, before the ceramide molecules were separated from the cultured skin model and determined by HPTLC. Figure 2 shows the amounts of each ceramide in the cultured skin model. The amounts of ceramide II, V, and VI were all increased a little by SPM-L application. However, the ceramide level was not influenced by the particle diameter of the SPM-L.
Change in the Ceramide Contents of the LabCyte Epi-Model after the Application of Different Sized SPM-L to the Stratum Corneum Side of the Cultured Skin Model
Next, 1.0% of different sized SPM-L was applied to the stratum corneum side of the epidermis of the LabCyte Epi-Model for 7 days. The skin model was cultured using the same method as described above. The ceramide molecules were separated from the cultured skin model and determined by HPTLC. Figure 3 shows the developed HPTLC plate image. Figure 4 shows the amount of each ceramide in the cultured skin. The amounts of ceramide II, V, and VI were significantly increased after the application of the small SPM-L.
Discussion
In this paper, various SPM-L were applied, and increases in the levels of several types of ceramide were observed in a three-dimensional cultured human skin model. We have reported that a cultured human skin model demonstrated sphingomyelinase activity and that SPM-L application to the three-dimensional cultured human skin model increased the amount of type II ceramide in the cultured skin [17] .
First, the change in the diameter of the SPM-L in PBS or culture medium was examined. The prepared SPM-L were ultracentrifuged and resuspended in PBS or culture medium. The diameter of the small SPM-L (110 and 190 nm) in PBS did not change, at least for 7 days. In contrast, the diameter of the large SPM-L (240 nm and without sizing) increased with time. The surface charge of the present SPM-L was -3.9 mV (data not shown), and it was assumed that the large liposomes became aggregated with the passage of time. SPM-L were applied to the basal layer of the model in order to evaluate their influence on the barrier function of the stratum corneum. When we applied the small SPM-L (110 or 190 nm in diameter), the levels of ceramide III and V in the model were increased a little. However, the diameter of the liposomes had little influence on the ceramide content of the model. As the liposome diameter increased, the amount of ceramide generated did not increase by much. It is suggested from the above findings that the interactions of SPM-L with cells are influenced by their diameter. When the SPM-L were applied to the stratum corneum side, the levels of ceramide II, III, V, and VI were significantly increased compared to those of the PBS group, especially when the small SPM-L (110 or 190 nm in diameter) were applied. It was also suggested that the penetration of the skin by the small liposomes (110 or 190 nm) was greater than that by the large liposomes (240 nm, MLV). In addition, the small SPM-L generated the most ceramide. This effect may have been higher with even smaller liposomes ( ! 100 nm). However, the preparation of small stable liposomes is difficult; therefore, it was not examined in this study.
In the present study, different sized liposomes were applied to the basal layer side or stratum corneum side of a Sphingosine cultured human skin model. As a result, the amounts of ceramide II, III, V, and VI in the skin were increased. Generally, major ceramides are generated through 2 pathways ( fig. 5 ). All species of ceramides can be produced through glucocerebrosidase activity, while only 2 species (type II and V ceramide) can be generated through the hydrolysis of SPM by sphingomyelinase [9, 13, 14] . These ceramides are then metabolized to sphingosine and free fatty acids by ceramidase [20] . Thus, the ceramide content of the stratum corneum is controlled by 3 enzymes: glucocerebrosidase, sphingomyelinase, and ceramidase. In this study, ceramide was not only generated by enzymatic reactions after the application of SPM-L. The factors of metabolism systems and/or signal trans-duction systems may be changed by the application of SPM-L. As a result, not only the levels of ceramide II and V but also those of ceramide III and VI were increased by the application of SPM-L. We will investigate the mechanism of ceramide generation in the skin by SPM-L in a future study.
Thus, the present SPM-L are effective at enriching the ceramide level of human skin. In addition, liposome formulations are very useful for the application of SPM to skin since the lipid itself is difficult to formulate in conventional formulations. Type II and V ceramide have been reported to be produced from SPM in the epidermis in vivo by sphingomyelinase. In a future study, we will investigate the changes in the amounts of other ceramides.
